L Catterton and Altas Partners acquire majority stake in Fullscript
The undisclosed transaction backs expansion of the practitioner-care platform and clinical support.
L Catterton and Altas Partners acquired a majority stake in Fullscript. The transaction value was not disclosed.
Fullscript will expand its platform and clinical support capabilities and extend its North American reach. The company reports serving more than 135,000 practitioners and 10 million patients annually through tools connecting care plans, supplements, diagnostics and follow-up.
Use of funds
Expand the platform and clinical support capabilities
Extend reach across the North American healthcare market